Proveca is a specialist pharmaceutical company developing medicines that improve the lives of children.
Proveca approached Inventya for help assessing the market for three potential paediatric medicines.
Our experts conducted proof-of-market research and market analysis, and within 6 months had delivered a full commercialisation plan. Inventya oversaw Proveca's successful proof-of-market grant application, resulting in grants totalling £75k. Proveca went on to secure £2.6m in venture capital investment.
Inventya shares Proveca's vision for the improving the lives of children, and are proud to have been part of their journey.
"Inventya have provided us with a brilliant commercial screening mechanism. Without Inventya's support we would not have been able to resource this level of research or secure our £2.6 million in venture capital investment."